BC
PMC

Bartlett & Co’s PharMerica Corporation PMC Stock Holding History

Bartlett & Co’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1
Closed – – 733
2013
Q4 		$0 Hold
1
– – ﹤0.01% 802
2013
Q3 		$0 Hold
1
– – ﹤0.01% 877
2013
Q2 		$0 Buy
+1
New +$14 ﹤0.01% 732

Other funds holding PMC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bartlett & Co's PMC Position: Q1 2014 in Review

Bartlett & Co sold out of PharMerica Corporation (PMC) in Q1 2014, closing a stake of 1 share.

Bartlett & Co first reported a position in PMC in Q2 2013 and held it in 3 quarters. The position peaked at $0 in Q4 2013. 161 funds tracked by Wall St. Rank hold PMC as of Q1 2014.

  • Bartlett & Co reported no remaining PharMerica Corporation position as of Q1 2014 after selling out during the quarter.
  • Bartlett & Co sold 1 PharMerica Corporation share in Q1 2014.
  • Bartlett & Co first reported a position in PharMerica Corporation in Q2 2013 and held it in 3 quarters.
  • Bartlett & Co's PharMerica Corporation position peaked at $0 in Q4 2013.
  • 161 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2014.

Based on Bartlett & Co's 13F filing for Q1 2014, filed 5 May 2014.